AADAC anticorps (AA 170-399)
Aperçu rapide pour AADAC anticorps (AA 170-399) (ABIN6136310)
Antigène
Voir toutes AADAC AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 170-399
-
Séquence
- KKVLAKYGVN PERIGISGDS AGGNLAAAVT QQLLDDPDVK IKLKIQSLIY PALQPLDVDL PSYQENSNFL FLSKSLMVRF WSEYFTTDRS LEKAMLSRQH VPVESSHLFK FVNWSSLLPE RFIKGHVYNN PNYGSSELAK KYPGFLDVRA APLLADDNKL RGLPLTYVIT CQYDLLRDDG LMYVTRLRNT GVQVTHNHVE DGFHGAFSFL GLKISHRLIN QYIEWLKENL
-
Réactivité croisée
- Humain, Souris
-
Attributs du produit
- Polyclonal Antibodies
-
Purification
- Affinity purification
-
Immunogène
- Recombinant fusion protein containing a sequence corresponding to amino acids 170-399 of human AADAC (NP_001077.2).
-
Isotype
- IgG
-
-
-
-
Indications d'application
- WB,1:500 - 1:2000,IHC,1:50 - 1:100
-
Commentaires
-
HIGH QUALITY
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
- AADAC (Arylacetamide Deacetylase (Esterase) (AADAC))
-
Autre désignation
- AADAC
-
Sujet
- Microsomal arylacetamide deacetylase competes against the activity of cytosolic arylamine N-acetyltransferase, which catalyzes one of the initial biotransformation pathways for arylamine and heterocyclic amine carcinogens,AADAC,CES5A1,DAC,Cancer,Signal Transduction,Endocrine & Metabolism,Drug metabolism,AADAC
-
Poids moléculaire
- 45 kDa
-
ID gène
- 13
-
UniProt
- P22760
Antigène
-